Category: T2 Biosystems Inc.Syndicate content

T2 Biosystems, Canon to develop Lyme disease test

February 5, 2015 by Val Kennedy

T2 Biosystems and Canon U.S. Life Sciences team up to develop a diagnostic test panel for the rapid detection of Lyme disease.

T2 Biosystems, Canon to develop Lyme disease test

T2 Biosystems (NSDQ:TTOO) and Canon U.S. Life Sciences are teaming up to develop a diagnostic test panel for the rapid detection of Lyme disease.

T2 Biosystems jumps on FDA nod for sepsis tests

September 24, 2014 by Alex Soule

Shares of T2 Biosystems jump nearly 10% after the FDA approves its MR-based tests designed to detect sepsis in a matter of hours rather than days.

T2 Biosystems jumps on FDA nod for sepsis tests

FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week of August 11, 2014

August 14, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Analyst report: Dems can't stop Medtronic-Covidien merger

T2 Biosystems IPO raises $57M for MRI-based diagnostics

August 7, 2014 by Arezu Sarvestani

Diagnostic devices maker T2 Biosystems raises $57 million in an initial public offering after pricing shares below range at $11 apiece.

T2 Biosystems IPO raises $57M for MRI-based diagnostics

Massachusetts-based (NSDQ:TTOO) fell below target with its initial public offering today, raising $57 million in support of its MRI-based diagnostic systems.

T2 Biosystems boosts IPO cap to $78.2M

July 30, 2014 by Arezu Sarvestani

MRI diagnostics maker T2 Biosystems releases details on its initial public offering, hoping to raise as much as $78.2 million at $17 per share.

T2 Biosystems boosts IPO to $72.8M

Massachusetts-based  raised its hopes for its upcoming initial public offering, raising its maximum aggregate take to $78.2 million if shares sell at $17 apiece.

T2 Biosystems prepares to go public in an offering that could garner $69 million | Medtech Wall Street news for the week of July 7, 2014

July 10, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: T2 Biosystems prepares $69M IPO for MRI-based diagnostics; Philips Healthcare retools, CEO DiSanzo is out; iRadimed sets terms for $10M IPO

T2 Biosystems prepares $69M IPO for MRI-based diagnostics

July 2, 2014 by Arezu Sarvestani

T2 Biosystems prepares to go IPO